1-9 of 9
Authors: Srihari Gopal
Journal Article
A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia Open Access
International Journal of Neuropsychopharmacology, Volume 25, Issue 3, March 2022, Pages 238–251, https://doi.org/10.1093/ijnp/pyab071
Published: 13 November 2021
Journal Article
PM531. Population Pharmacokinetic/Pharmacodynamic Modeling of Paliperidone Palmitate 3-Month Formulation in Asian Population Free
International Journal of Neuropsychopharmacology, Volume 19, Issue Suppl_1, June 2016, Page 93, https://doi.org/10.1093/ijnp/pyw041.531
Published: 27 May 2016
Journal Article
PM409. Paliperidone Palmitate 3-Monthly vs. 1-Monthly Injectable in Schizophrenia Patients with or without Prior Exposure to Oral Risperidone or Paliperidone Free
International Journal of Neuropsychopharmacology, Volume 19, Issue Suppl_1, June 2016, Pages 48–49, https://doi.org/10.1093/ijnp/pyw041.409
Published: 27 May 2016
Journal Article
PM410. Comparison of 3-Monthly versus 1-Monthly Paliperidone Palmitate for Time to Onset and Time to Resolution of Extrapyramidal Symptoms in Patients with Exacerbated Schizophrenia Free
International Journal of Neuropsychopharmacology, Volume 19, Issue Suppl_1, June 2016, Page 49, https://doi.org/10.1093/ijnp/pyw041.410
Published: 27 May 2016
Journal Article
PM386. An Assessment of Injection Site Reactions and Injection Site Pain of Once-Every One Month and Three-Month Long-Acting Injectable Formulations of Paliperidone Palmitate Free
International Journal of Neuropsychopharmacology, Volume 19, Issue Suppl_1, June 2016, Page 41, https://doi.org/10.1093/ijnp/pyw041.386
Published: 27 May 2016
Journal Article
PM532. Symptomatic Remission and Functional Recovery after Paliperidone Palmitate 3-monthly or 1-monthly treatment in Asian Patients with Exacerbated Schizophrenia Free
International Journal of Neuropsychopharmacology, Volume 19, Issue Suppl_1, June 2016, Pages 93–94, https://doi.org/10.1093/ijnp/pyw041.532
Published: 27 May 2016
Journal Article
Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study Open Access
International Journal of Neuropsychopharmacology, Volume 19, Issue 7, July 2016, pyw018, https://doi.org/10.1093/ijnp/pyw018
Published: 22 February 2016
Journal Article
A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia – Corrigendum Free
International Journal of Neuropsychopharmacology, Volume 15, Issue 1, February 2012, Page 119, https://doi.org/10.1017/S146114571100160X
Published: 01 February 2012
Journal Article
A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia Free
International Journal of Neuropsychopharmacology, Volume 15, Issue 1, February 2012, Pages 107–118, https://doi.org/10.1017/S1461145711001076
Published: 01 February 2012
